We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Handheld Device Puts Power of Lab-Based Diagnostic Testing in the Palm of Your Hand

By LabMedica International staff writers
Posted on 24 Jul 2024
Print article
Image: The LIAMT handheld processor features a window which the user can look through to view fluorescent virus detection signals (Photo courtesy of Ziyue Li)
Image: The LIAMT handheld processor features a window which the user can look through to view fluorescent virus detection signals (Photo courtesy of Ziyue Li)

Many common tests for infectious diseases work by detecting either antigens related to the virus or antibodies created in response to the infection. These tests, which now include widely used COVID-19 rapid antigen tests, offer the advantages of speed and broad availability. However, polymerase chain reaction (PCR) tests still surpass these in terms of accuracy, reaching nearly 100%. PCR tests, considered the gold standard in infectious disease diagnostics, excel because they detect a pathogen’s genetic material like RNA directly. This capability increases specificity, reducing the likelihood of false positives. PCR can also amplify minimal amounts of genetic material, allowing it to detect infections at very low levels. Yet, PCR requires specialized skills and expensive equipment, which limits its availability, particularly in low-resource settings.

Researchers at the University of Connecticut (Storrs, CT, USA) have now developed a platform technology that incorporates PCR-like capabilities within a handheld device, as detailed in a study published in Advanced Science. This device can detect HIV and SARS-CoV-2 with PCR-level performance but is more accessible, faster, and portable, potentially making advanced diagnostics more widespread. This new device, the lab-in-a-magnetofluidic tube (LIAMT), integrates all necessary functions into a single, portable unit unlike the multiple large machines required for PCR. LIAMT simplifies the isolation of genetic material by using magnetism instead of centrifugation. It employs tiny magnetic beads within a 1.5-milliliter tube to capture viral RNA, which is then pulled through washing steps by a magnet inside the device, effectively isolating the RNA. LIAMT does not require the thermal cycling equipment typical of PCR. Instead, it uses a constant, low-temperature process facilitated by special proteins that separate and duplicate nucleic acid strands. After amplification, the LIAMT device slightly heats the sample to melt a wax barrier, releasing a solution of CRISPR enzymes that emit a fluorescent signal upon binding to their target. This signal indicates the presence of viral RNA if it's substantial enough, visible through a small window on the device.

This system, devoid of heavy equipment like centrifuges and thermal cyclers, offers a significant advancement in making diagnostic tools more accessible and faster—producing results within about an hour compared to the longer processes associated with traditional PCR, where samples often need to be sent away for analysis. To verify its effectiveness, researchers tested LIAMT against traditional PCR using swab samples for SARS-CoV-2 and blood plasma samples for HIV. The results showed LIAMT to have comparable sensitivity and specificity, aligning closely with PCR results in most cases. Encouraged by these findings, the researchers plan to further refine LIAMT’s performance and usability, particularly to enhance care for HIV patients who require regular testing. This could transform routine testing by eliminating the need for hospital visits and lengthy waits, offering instead rapid, reliable results at the point of care.

“With our device, we used the volume you could get from a finger prick to produce accurate HIV test results quickly. Patients could take these tests at a local point-of-care center or at home and receive the medication they need more quickly,” said Changchun Liu, Ph.D., a professor of biomedical engineering at the University of Connecticut.

Related Links:
University of Connecticut

New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Leishmania Test
Leishmania Real Time PCR Kit
New
Human Immunodeficiency Virus Assay
RealLine HIV Quantitative Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.